SCAL1 knockdown may sensitize cancer cells to targeted therapies by allowing anti-proliferative, anti-migratory and cell death signals to put the brakes on tumor growth, metastatic spread and resistance to apoptosis. This evidence concerns the gene LUCAT1 and neoplasm.